| 书目名称 | Combination Cancer Therapy | | 副标题 | Modulators and Poten | | 编辑 | Gary K. Schwartz | | 视频video | | | 概述 | Includes supplementary material: | | 丛书名称 | Cancer Drug Discovery and Development | | 图书封面 |  | | 描述 | Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient‘s bedside for the future treatments in cancer therapy. | | 出版日期 | Book 2005 | | 关键词 | Chemotherapie; apoptosis; carcinoma; cell; leukemia; ovarian cancer | | 版次 | 1 | | doi | https://doi.org/10.1385/1592598641 | | isbn_softcover | 978-1-62703-806-5 | | isbn_ebook | 978-1-59259-864-9Series ISSN 2196-9906 Series E-ISSN 2196-9914 | | issn_series | 2196-9906 | | copyright | Humana Press 2005 |
The information of publication is updating
|
|
发表于 2025-3-21 17:41:59
